RING-COX

Description

ACID SECRETION SUPPRESSOR + NSAID

Colombia Reg. ICA No.: 10310-MV

1. GUARANTEED COMPOSITION:
Each mL of RING-COX contains:
Famotidine 5 mg
Meloxicam 1 mg
Excipients q.s. to 1 mL

2. INDICATIONS:
RING-COX is indicated in dogs for the treatment of acute pain and inflammation.
For the prevention and control of gastritis and gastric ulcers associated with treatment with non-steroidal analgesics.

3. SPECIES FOR WHICH IT IS RECOMMENDED:
Dogs.

4. ROUTE OF ADMINISTRATION:
Oral use only.

5. DOSAGE:
Administer on the first day a single dose of 0.2 mg/kg of body weight (equivalent to 1 mL/5 kg).
From the second day of treatment, a dose of 0.1 mg/kg of body weight (equivalent to 0.5 mL/5 kg) is suggested, every 24 hours for a maximum of 5 days.
The duration of the treatment MUST NEVER exceed 5 days.

6. PRECAUTIONS:
Shake well before use.
Administer only orally.
For veterinary use in dogs only.
The prescribed dose must be administered with precision.
Evaluate the risk-benefit ratio in patients with a history of hepatic or renal disease.
Do not administer to patients with chronic liver or kidney disorders.
When administered with food, it must be ensured that all the medication is consumed.
In cases of hypersensitivity or adverse effects following administration, treatment must be discontinued.
Store at a temperature below 30 ºC, protected from light.

CONTRAINDICATIONS:
Do not administer to dogs with known hypersensitivity to the medication.
Do not use in animals that are pregnant, lactating, or under 6 weeks of age.

7. MANDATORY STATEMENTS:
Sale by prescription of a Veterinarian.
Consult your Veterinarian.
Keep out of reach of children and domestic animals.
Final disposal of empty containers or containers with residual content must be carried out in accordance with current environmental regulations.
Veterinary use.

8. PRESENTATIONS:
Registered: Bottle of 15, 30, 60 or 120 mL.